Cardioverter Defibrillator Devices Market, Global Outlook and Forecast 2023-2032
Increasing prevalence of cardiovascular disease, sudden cardiac arrest (SCA), and related death remains a significant public health issue across the globe. Variety of non-pharmacologic therapies for primary and secondary prevention of SCA and their management including implantable and wearable defibrillators are available in the market. Cardioverter defibrillators have become a significant therapeutic modality among all for patients who have had a cardiac arrest or are at risk for life-threatening ventricular arrhythmias.
This report aims to provide a comprehensive presentation of the global market for Cardioverter Defibrillator Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardioverter Defibrillator Devices. This report contains market size and forecasts of Cardioverter Defibrillator Devices in global, including the following market information:
Global Cardioverter Defibrillator Devices Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Cardioverter Defibrillator Devices Market Sales, 2018-2023, 2024-2032, (Units)
Global top five Cardioverter Defibrillator Devices companies in 2022 (%)
The global Cardioverter Defibrillator Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Implantable Cardioverter Defibrillator Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cardioverter Defibrillator Devices include Fukuda Denshi(Japan), LivaNova(U.K.), Medtronic(Ireland), Progetti(Italy), Schiller(Switzerland), Abbott Laboratories(U.S.), BIOTRONIK(Germany), Boston Scientific Corporation(U.S.) and Cardiac Science corporation(U.S.), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Cardioverter Defibrillator Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardioverter Defibrillator Devices Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (Units)
Global Cardioverter Defibrillator Devices Market Segment Percentages, by Type, 2022 (%)
Implantable Cardioverter Defibrillator
External Cardioverter Defibrillator
Global Cardioverter Defibrillator Devices Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (Units)
Global Cardioverter Defibrillator Devices Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgery Centers
Others
Global Cardioverter Defibrillator Devices Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (Units)
Global Cardioverter Defibrillator Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardioverter Defibrillator Devices revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cardioverter Defibrillator Devices revenues share in global market, 2022 (%)
Key companies Cardioverter Defibrillator Devices sales in global market, 2018-2023 (Estimated), (Units)
Key companies Cardioverter Defibrillator Devices sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fukuda Denshi(Japan)
LivaNova(U.K.)
Medtronic(Ireland)
Progetti(Italy)
Schiller(Switzerland)
Abbott Laboratories(U.S.)
BIOTRONIK(Germany)
Boston Scientific Corporation(U.S.)
Cardiac Science corporation(U.S.)
Koninklijke Philips(Netherlands)
Nihon Kohden Corporation(Japan)
Stryker Corporation(U.S.)
Zoll medical corporation(U.S.)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardioverter Defibrillator Devices, market overview.
Chapter 2: Global Cardioverter Defibrillator Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Cardioverter Defibrillator Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardioverter Defibrillator Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cardioverter Defibrillator Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
